| Factor Information | |
|---|---|
| Data ID | 867 |
| Factor | predischarge SAVV regurgitation grade |
| Description | Adults with congenital heart disease (ACHD) undergoing systemic atrioventricular valve (SAVV) surgery are a complex, understudied population |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We assessed midterm outcomes and prognostic factors in ACHD undergoing SAVV surgery |
| p Value | =0.045 |
| OR | 8.2 |
| Conclusion | Overall outcomes in this challenging population are good. The single factor associated with adverse events was predischarge SAVV regurgitation grade. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 486 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/ccTGA/MS, MR |
| Reference | |
|---|---|
| PMID | 28520541 |
| Year | 2017 |
| Title | Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | retrospective cohort study | |
| Region | New York, USA | |
| Method | retrospective evaluation | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | SAVV surgery | |
| Group | Patients With CHD(Treatment) | N/A(Control) |
| Number | 43(Total) | N/A |
| Age | 35.2 ± 12.4 years | N/A |
| Gender (Male: Female) | 20:23 | N/A |
| Marker Level | N/A | N/A |
